GABPA and malignant colon neoplasm: Similarly, luteolin (7.5, 15, and 30 μM) decreased colon cancer proliferation through epigenetic modifications of the Nrf2 gene and subsequent activation of HO-1 and NQO1 (Table 2) [101].